Brief: Noxopharm Seeks Trading Halt
03/10/2023 03:34
Oct 3 (Reuters) - Noxopharm Ltd NOX.AX :
* NOXOPHARM LTD - SEEKS TRADING HALT PENDING ANNOUNCEMENT ON
DETERMINATION OF DESIGNATION BY FDA FOR PANCREATIC CANCER DRUG
CANDIDATE CRO-67
Source text for Eikon: ID:nASXb1Z3Rx
Further company coverage: NOX.AX
(Reporting by Roshan Thomas)
((Roshan.Thomas@thomsonreuters.com;))
Recent news on Noxopharm
See all newsBrief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential
Brief: Noxopharm Says New Data Confirms Cancer-Fighting Potential
Brief: Noxopharm Appoints Dr Olivier Laczka As New CEO
Brief: Noxopharm Ltd Announces Resignation Of Chief Executive Officer